QPPV.COM KNOWLEDGE ASSESSMENT

Pharmacovigilance Record Retention and Archiving

Test your understanding of the concepts covered by Pharmacovigilance Record Retention and Archiving.

Question 1 of 10Pass mark: 80%

Question 1 of 10 A global company is setting a retention period for a clinical-study safety record that is also used in PV. What is the most appropriate approach?
Question 2 of 10 A case is held in a safety database, an intake mailbox and a document repository. What should the retention schedule do to reduce the risk of inconsistent or competing copies?
Question 3 of 10 An MAH formally terminates the PV system described in its PSMF. Which records are associated with the five-year minimum in Article 12(2)?
Question 4 of 10 Electronic records are deleted from the active repository, but residual backup copies remain until the normal backup cycle expires. Which control best addresses the risk that expired records reappear?
Question 5 of 10 A company finds that an older GVP statement appears inconsistent with amended legislation. Which approach is most appropriate?
Question 6 of 10 An organisation discovers that a legacy record can be opened but its status codes and date conventions are no longer understood. What best describes the problem?
Question 7 of 10 A PV service-provider contract states that records will be available on request. Which additional action best supports assurance that access will work after the provider relationship ends?
Question 8 of 10 A retrieval test succeeds for recent records in the current database. Why might that result provide limited assurance about the full archive?
Question 9 of 10 Which statement best describes the relationship between the PSMF and the broader PV record-retention schedule?
Question 10 of 10 An organisation retains its PV data in a system backup that is routinely overwritten after a short recovery cycle. Why is this not, by itself, an adequate archive?

Select an answer to continue.

QPPV.com